Imac Holdings Inc (BACK)

$0.07 -0.13 (-64.50%)
Market Cap 887,000.00
Revenue (ttm) 0.00
Net Income (ttm) -9.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 859,700
Avg Vol 1,744,240
Day's Range N/A - N/A
Shares Out 2.07M
Stochastic %K 15%
Beta 0.16
Analysts Sell
Price Target $8.25

Company Profile

IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 303 898 5896
Address:
3401 Mallory Lane, Suite 100, Franklin, United States
ChipDistribution7
ChipDistribution7 Apr. 14 at 3:22 AM
$BACK. Goldman Sachs Group Inc. reported a strong Q1 2026 with revenue at $17.23B (+14% YoY) and EPS of $17.55, beating estimates. Net income reached $5.63B (+19% YoY), supported by strength across trading and investment banking. The key driver was investment banking, where fees surged +48%, signaling a clear rebound in deal activity, including M&A and renewed capital markets issuance. This points to improving risk appetite and a healthier deal cycle. The result ranks among the strongest quarters outside the 2021 peak, highlighting a broader recovery in capital markets activity.
0 · Reply
DisneyPalaceTrades
DisneyPalaceTrades Mar. 26 at 2:58 AM
$BACK this used to pop like every 2 weeks
0 · Reply
FightingIrish33
FightingIrish33 Feb. 6 at 11:30 PM
$RDW $BACK to $14 next week.....
1 · Reply
AlphaTuna
AlphaTuna Feb. 6 at 12:44 AM
Lowest Volume Rated General Stocks Per 2/5/2026’s Close: 1 – $FUNI 2 – $RKMSF 3 – $OMQS 4 – $AIJTY 5 – $SRBIF 6 – $BACK 7 – $HLP 8 – $UBAB 9 – $NPRLF 10 – $WACLY https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-2-5-2026/
0 · Reply
Godwins26
Godwins26 Jan. 24 at 12:02 AM
$BNAI run it $BACK with $XTKG 😊
0 · Reply
MaxProfitTrades
MaxProfitTrades Dec. 27 at 3:01 AM
$BACK On my Watchlist
0 · Reply
TheRealDiamondJim
TheRealDiamondJim Dec. 25 at 3:37 AM
$EAT $AT $OUT $BACK
0 · Reply
Steveo1k
Steveo1k Dec. 4 at 9:47 PM
$BACK $NMAX I need it’s to go up %4000 please God. Please let there be Good news for us. So I can spread the blessing 😇🙏🫡🌍🔮⏳🆒🎁
0 · Reply
Steveo1k
Steveo1k Dec. 4 at 9:46 PM
$BACK $NMAX
0 · Reply
Geestar
Geestar Nov. 4 at 8:28 PM
$BACK below 190 after AMD disasterous ER
0 · Reply
Latest News on BACK
Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers

Sep 10, 2025, 3:04 PM EDT - 8 months ago

Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers

IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery

Aug 7, 2025, 4:05 PM EDT - 9 months ago

IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery

Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference

Feb 24, 2025, 8:15 AM EST - 1 year ago

Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference

Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay

Feb 19, 2025, 9:15 AM EST - 1 year ago

Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay

Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response

Feb 10, 2025, 9:15 AM EST - 1 year ago

Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response

IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies

Jan 27, 2025, 4:10 PM EST - 1 year ago

IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

Nov 22, 2024, 5:15 PM EST - 1 year ago

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)

Nov 14, 2024, 9:10 AM EST - 1 year ago

IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology

Sep 19, 2024, 10:00 AM EDT - 1 year ago

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology

IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors

Jul 11, 2024, 9:21 AM EDT - 1 year ago

IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors

IMAC Holdings Announces Leadership Succession

May 24, 2024, 9:00 AM EDT - 2 years ago

IMAC Holdings Announces Leadership Succession

IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business

May 7, 2024, 8:30 AM EDT - 2 years ago

IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

Sep 27, 2023, 4:30 PM EDT - 2 years ago

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Sep 7, 2023, 12:45 PM EDT - 2 years ago

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

Jul 26, 2023, 9:25 AM EDT - 2 years ago

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

IMAC Holdings Annual Meeting of Shareholders Reminder

Jun 28, 2023, 4:30 PM EDT - 3 years ago

IMAC Holdings Annual Meeting of Shareholders Reminder

THERALINK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Theralink Technologies, Inc. - THER

May 30, 2023, 11:04 PM EDT - 3 years ago

THERALINK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Theralink Technologies, Inc. - THER

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

May 23, 2023, 9:43 AM EDT - 3 years ago

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update

Mar 31, 2023, 8:00 PM EDT - 3 years ago

IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update

IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution

Mar 20, 2023, 7:30 AM EDT - 3 years ago

IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution

IMAC Holdings, Inc announces the sale of The BackSpace

Mar 1, 2023, 9:30 AM EST - 3 years ago

IMAC Holdings, Inc announces the sale of The BackSpace

IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership

Oct 21, 2022, 10:30 AM EDT - 3 years ago

IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership

IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Sep 9, 2022, 9:22 AM EDT - 3 years ago

IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Biote Announces Strategic Partnership with IMAC Holdings, Inc.

Sep 7, 2022, 8:30 AM EDT - 3 years ago

Biote Announces Strategic Partnership with IMAC Holdings, Inc.

BTMD

IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers

Sep 1, 2022, 9:44 AM EDT - 3 years ago

IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers

IMAC Holdings, Inc. Announces Closing of $3.9 Million Registered Direct and Private Placement Offerings

Aug 16, 2022, 4:00 PM EDT - 4 years ago

IMAC Holdings, Inc. Announces Closing of $3.9 Million Registered Direct and Private Placement Offerings

IMAC Holdings Reports Record Revenue of $5M in Second Quarter

Aug 15, 2022, 11:30 AM EDT - 4 years ago

IMAC Holdings Reports Record Revenue of $5M in Second Quarter

IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement

Aug 12, 2022, 9:16 AM EDT - 4 years ago

IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement

ChipDistribution7
ChipDistribution7 Apr. 14 at 3:22 AM
$BACK. Goldman Sachs Group Inc. reported a strong Q1 2026 with revenue at $17.23B (+14% YoY) and EPS of $17.55, beating estimates. Net income reached $5.63B (+19% YoY), supported by strength across trading and investment banking. The key driver was investment banking, where fees surged +48%, signaling a clear rebound in deal activity, including M&A and renewed capital markets issuance. This points to improving risk appetite and a healthier deal cycle. The result ranks among the strongest quarters outside the 2021 peak, highlighting a broader recovery in capital markets activity.
0 · Reply
DisneyPalaceTrades
DisneyPalaceTrades Mar. 26 at 2:58 AM
$BACK this used to pop like every 2 weeks
0 · Reply
FightingIrish33
FightingIrish33 Feb. 6 at 11:30 PM
$RDW $BACK to $14 next week.....
1 · Reply
AlphaTuna
AlphaTuna Feb. 6 at 12:44 AM
Lowest Volume Rated General Stocks Per 2/5/2026’s Close: 1 – $FUNI 2 – $RKMSF 3 – $OMQS 4 – $AIJTY 5 – $SRBIF 6 – $BACK 7 – $HLP 8 – $UBAB 9 – $NPRLF 10 – $WACLY https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-2-5-2026/
0 · Reply
Godwins26
Godwins26 Jan. 24 at 12:02 AM
$BNAI run it $BACK with $XTKG 😊
0 · Reply
MaxProfitTrades
MaxProfitTrades Dec. 27 at 3:01 AM
$BACK On my Watchlist
0 · Reply
TheRealDiamondJim
TheRealDiamondJim Dec. 25 at 3:37 AM
$EAT $AT $OUT $BACK
0 · Reply
Steveo1k
Steveo1k Dec. 4 at 9:47 PM
$BACK $NMAX I need it’s to go up %4000 please God. Please let there be Good news for us. So I can spread the blessing 😇🙏🫡🌍🔮⏳🆒🎁
0 · Reply
Steveo1k
Steveo1k Dec. 4 at 9:46 PM
$BACK $NMAX
0 · Reply
Geestar
Geestar Nov. 4 at 8:28 PM
$BACK below 190 after AMD disasterous ER
0 · Reply
GODDY1
GODDY1 Oct. 18 at 12:47 AM
$BA $BACK to $220+ next week..let’s go!
0 · Reply
makinmon3y
makinmon3y Sep. 3 at 6:18 PM
$QQQ $BACK to $560 by 4pm friday. $TQQQ $SQQQ
1 · Reply
Hourib
Hourib Aug. 26 at 11:30 AM
$INHD POS move up… MF need to get my $BACK
0 · Reply
apppro
apppro Aug. 13 at 4:11 PM
It's all about getting @realDonaldTrump Time for @AGPamBondi to shut this horror in NY down Cc @SecScottBessent @lizpeek @KatiePavlich $JPM $BACK $WFC
0 · Reply
MessengerOfGod
MessengerOfGod Jul. 11 at 5:44 PM
$BACK A reverse split then 📉 📉 POS fraud company
0 · Reply
TritiumH3
TritiumH3 Jul. 8 at 11:39 PM
$BACK it's ok
0 · Reply
t51
t51 Jun. 23 at 3:19 PM
$KTA.X $V $BACK “Rumors” can be harmful to your financial health.
2 · Reply
dln101
dln101 May. 15 at 4:32 PM
$CNEY bounce from here with $BACK $VYNT 🤔💪🔥🚀
0 · Reply
Nooneanymore
Nooneanymore May. 13 at 1:46 PM
$QQQ $BACK to $507.22 93%
3 · Reply